open access
Cardiovascular comorbidity and death from COVID-19: Prevalence and differential characteristics
Affiliations- Hospital Clínico San Carlos, Profesor Martín Lagos s/n, 28040 Madrid, Spain
open access
Abstract
Abstract
About this articleTitle
Cardiovascular comorbidity and death from COVID-19: Prevalence and differential characteristics
Journal
Issue
Article type
Research Letter
Pages
339-341
Published online
2021-02-16
Page views
741
Article views/downloads
795
DOI
Pubmed
Bibliographic record
Cardiol J 2021;28(2):339-341.
Authors
Julia Playán-Escribano
Zaira Gómez-Álvarez
Teresa Romero-Delgado
Carlos Nicolás Pérez-García
Daniel Enríquez-Vázquez
Isidre Vilacosta
References (9)- Ministerio de Sanidad, Consumo y Bienestar Social. Actualización nº 258. Enfermedad por el coronavirus (COVID-19). 2020. https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_135_COVID-19.pdf (Accessed November 26th 2020).
- European Society of Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. 2020. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance (Accessed November 26th 2020).
- Kowalik MM, Trzonkowski P, Łasińska-Kowara M, et al. COVID-19 - Toward a comprehensive understanding of the disease. Cardiol J. 2020; 27(2): 99–114.
- Gąsecka A, Filipiak KJ, Jaguszewski MJ. Impaired microcirculation function in COVID-19 and implications for potential therapies. Cardiol J. 2020; 27(5): 485–488.
- Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009; 64 Suppl 3: iii1–ii55.
- Onder G, Rezza G, Brusaferro S. Case-Fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020; 323(18): 1775–1776.
- Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020; 58(7): 1131–1134.
- Lorente-Ros A, Monteagudo Ruiz JM, Rincón LM, et al. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients. Cardiol J. 2020; 27(5): 489–496.
- Kim JS, Kim M, Kim YJ, et al. Troponin testing for assessing sepsis-induced myocardial dysfunction in patients with septic shock. J Clin Med. 2019; 8(2).
